OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	77
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	59
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	51
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	43
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis	39
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	36
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	30
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial	29
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	27
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	26
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	25
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	24
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting	22
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	22
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	19
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use	18
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study	17
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial	17
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	16
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	16
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	16
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder	16
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024	16
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps	15
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study	15

“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda	14
Proceedings of the 18th Annual Conference of INEBRIA	14
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham	14
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	13
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods	13
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits	13
Substance use disorder bridge clinics: models, evidence, and future directions	12
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	12
An investigation of fentanyl and methamphetamine use among first-time arrestees from 25 county jails across the U.S. in 2023	12
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program	11
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa	11
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder	11
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics	11
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study	10
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions	10
A systematic review of substance use screening in outpatient behavioral health settings	10
The development and initial validation of the Russian version of the BASIS-24	10
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches	10
Patient experiences of buprenorphine dispensing from a mobile medical unit	9
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders	9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	9
Automated Reinforcement Management System (ARMS): focused phase I provider feedback	9
Rethinking trazodone for insomnia in alcohol use disorder	8
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	8
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	8
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	8
Comparison of heroin and fentanyl use in US nationally representative surveys	8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	8
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	8
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries	8
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	8
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	8
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	8
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol	8
Attitudes and training related to substance use in pediatric emergency departments	7
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	7
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	7
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	7
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	7
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States	7
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	7
Proceedings of the 17th Annual International INEBRIA Conference	7
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review	7
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	7
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	7
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	7
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper	7
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	7
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany	6

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu	6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	6
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial	6
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single	6
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare	6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors	6
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	6
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs	6
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population	6
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	6
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	6
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa	6